These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3669276)

  • 21. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy.
    Nickenig G; Wolff M; Stäblein A; Pfister H; Böhm M
    Biochem Biophys Res Commun; 1999 Dec; 266(2):432-6. PubMed ID: 10600520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical, laboratory and instrumental criteria for myocarditis, established in comparison with myocardial biopsy: A non-invasive diagnostic algorithm].
    Blagova OV; Osipova YV; Nedostup AV; Kogan EA; Sulimov VA
    Ter Arkh; 2017; 89(9):30-40. PubMed ID: 29039828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoadsorption in dilated cardiomyopathy.
    Staudt A; Felix SB
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-lymphocyte subsets as noninvasive markers of cardiomyopathy.
    Kanda T; Yokoyama T; Ohshima S; Yuasa K; Watanabe T; Suzuki T; Murata K
    Clin Cardiol; 1990 Sep; 13(9):617-22. PubMed ID: 2145109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins.
    Mándi Y; Hogye M; Talha EM; Skolák E; Csanády M
    Pathobiology; 2000; 68(3):150-8. PubMed ID: 11174073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Humoral immunity and lymphocyte subsets in patients with dilated cardiomyopathy].
    Maruta M; Takenaka K; Takabe H; Akiyama T; Obana Y; Furuta I; Ohba Y
    Rinsho Byori; 1991 Aug; 39(8):824-8. PubMed ID: 1920877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological status and pathology of coxsackie B viral myocarditis and dilated cardiomyopathy.
    Chen SX; Mei SW; Bao SH; Zheng XJ; Chang PL; Yao JS; Yao S; Zhang DQ
    Chin Med J (Engl); 1993 Sep; 106(9):659-64. PubMed ID: 8287699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Peripheral T-lymphocyte subpopulations in primary and alcoholic dilated cardiomyopathy].
    Sachs RN; Hatron PY; Saizy C; Lanfranchi J
    Ann Med Interne (Paris); 1985; 136(3):229-32. PubMed ID: 3161445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
    Warraich RS; Dunn MJ; Yacoub MH
    Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Immune Profiles in Fetal Hearts with Idiopathic Dilated Cardiomyopathy, Maternal Autoimmune-Associated Dilated Cardiomyopathy and the Normal Fetus.
    Nield LE; von Both I; Popel N; Strachan K; Manlhiot C; Shannon P; McCrindle BW; Atkinson A; Miner SE; Jaeggi ET; Taylor GP
    Pediatr Cardiol; 2016 Feb; 37(2):353-63. PubMed ID: 26481221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ analysis with monoclonal antibodies of lymphocyte subsets in myocardial biopsies from patients with dilated cardiomyopathy and idiopathic (viral) myocarditis.
    Deguchi H; Hayashi T; Kotaka M; Nakayama Y; Kitaura Y; Kawamura K
    Jpn Circ J; 1987 Dec; 51(12):1365-72. PubMed ID: 3443989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac cytotoxic mechanism mediated by antibodies against myocardial mitochondrial ADP/ATP carrier in patients with dilated cardiomyopathy.
    Liao Y; Tu Y; Chen L; Dai S; Peng Y; Li S; Zhang J
    Chin Med J (Engl); 1996 Mar; 109(3):193-6. PubMed ID: 8758307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoadsorption in dilated cardiomyopathy.
    Felix SB
    Ernst Schering Res Found Workshop; 2006; (55):353-61. PubMed ID: 16329672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.
    Maisch B; Deeg P; Liebau G; Kochsiek K
    Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dilated cardiomyopathy--heart muscle disease of unknown origin or an autoimmune disease? New aspects of etiology, pathogenesis and clinical practice].
    Müller S
    Z Gesamte Inn Med; 1989 Aug; 44(16):469-76. PubMed ID: 2683430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dilated cardiomyopathy: sequela of viral myocarditis?].
    Kipshidze NN
    Kardiologiia; 1989 Nov; 29(11):75-9. PubMed ID: 2559232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.
    Noutsias M; Pauschinger M; Schultheiss H; K hl U
    Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.